G.J.S. Rustin - Concepedia

Author

G.J.S. Rustin

Also Known As

G J Rustin, G J S Rustin, G RUSTIN, G Rustin, G. J. Rustin, G. J. S. RUSTIN, G. J. S. Rustin, G. Rustin, G.J. Rustin, G.J.S Rustin

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Charing Cross Hospital Mount Vernon Hospital Gynecologic Oncology Group Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe European Organisation for Research and Treatment of Cancer

About

G.J.S. Rustin is an author at Charing Cross Hospital specializing in medicine, oncology, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	24	1.9K
2	Public Health	4	4	555
3	Health Sciences	2	2	144
4	Immunology	2	2	50
5	Health Policy	1	1	24

G.J.S. Rustin

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004) Andreas du Bois, Michael Quinn, Tate Thigpen, Annals of Oncology MedicineCancer ManagementReproductive HealthGynecologyGcig Occc 2004	2005	465
Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125. G.J.S. Rustin, Ann E. Nelstrop, Patrick McClean, Journal of Clinical Oncology	1996	377
Defining progression of ovarian carcinoma during follow-up according to CA 125: A North Thames Ovary Group study G.J.S. Rustin, Ann E. Nelstrop, Malgorzata Tuxen, Annals of Oncology Tumoral PathologyCa 125MedicineGynecologyOvarian Carcinoma	1996	284
Advanced epithelial ovarian cancer: 1993 consensus statements Darlene Allen, J. Baak, D Belpomme, Annals of Oncology Gynecological SurgeryMedicineGynecologyConsensus StatementsOncology	1993	185
Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. G.J.S. Rustin, E.S. Newlands, Jean Michel Lutz, Journal of Clinical Oncology	1996	184
Surveillance policy for stage I ovarian germ cell tumors. G. Dark, Mark Bower, E.S. Newlands, Journal of Clinical Oncology	1997	137
A randomized trial of five versus eight courses of cisplatin or carboplatin in advanced epithelial ovarian carcinoma H Lambert, G.J.S. Rustin, Walter M. Gregory, Annals of Oncology Versus EightMedicineCancer ManagementGynecologyRandomized Trial	1997	121
Randomised double-blind phase III trial of cediranib (AZD 2171) in relapsed platinum sensitive ovarian cancer: Results of the ICON6 trial JA Ledermann, Timothy Perren, FA Raja, UCL Discovery (University College London) Azd 2171MedicineMetronomic TherapyClinical TrialsGynecology	2013	102
Radiotherapy after chemotherapy for metastatic seminoma—a diminishing role Gillian Duchesne, Sally Stenning, Nina Aass, European Journal of Cancer Radiation MedicineRadiation TherapyMedicineMetastatic Seminoma—aOncology	1997	88
Ondansetron Compared with Metoclopramide in the Control of Emesis and Quality of Life during Repeated Chemotherapy for Breast Cancer M. Soukop, B. McQuade, E Hunter, Oncology	1992	88

Page 1